Key result
Review identifies thrombosis, inflammation, intimal hyperplasia, and atherosclerosis as primary drivers of SVG failure.
Why the study?
The saphenous vein remains the most frequently used conduit for CABG despite unsatisfactory long-term patency rates, motivating a review of vein graft failure pathophysiology and potential new intervention strategies.
What are the pathophysiological mechanisms, prevention strategies, and treatments for saphenous vein graft failure?
Design
Literature review
Authors
Loading...
Surgical and pharmacological strategies improve early SVG patency; leaves open durable long-term prevention.
What are the pathophysiological mechanisms, prevention strategies, and treatments for saphenous vein graft failure?
This review summarizes the pathophysiology of saphenous vein graft failure and highlights that while surgical and pharmacological interventions improve early patency, long-term patency remains a challenge requiring further research.
Guida et al. (2020) conducted a review in Saphenous vein graft disease. A review of the literature indicates that saphenous vein graft failure is driven by thrombosis, inflammation, intimal hyperplasia, and atherosclerosis, with various strategies proposed for prevention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: